Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Carbohydr Res ; 532: 108918, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37586142

ABSTRACT

A triazolylsialoside-human serum albumin conjugate was prepared as a multivalent hemagglutinin and neuraminidase inhibitor using a di-(N-succinimidyl) adipate strategy. Matrix-Assisted Laser Desorption/Ionization-Time of Flight-Mass Spectrometry (MALDI-TOF-MS) indicated that five tetravalent sialyl galactosides were grafted onto the protein backbone resulting in an eicosavalent triazolylsialoside-protein complex. Compared with monomeric sialic acid, molecular interaction studies showed that the synthetic pseudo-glycoprotein bound tightly not only to hemagglutinin (HA)/neuraminidase (NA) but also to mutated drug-resistant NA on the surface of the influenza virus with a dissociation constant (KD) in the 1 µM range, attributed to the cluster effect. Moreover, this glycoconjugate exhibited potent antiviral activity against a broad spectrum of virus strains and showed no cytotoxicity towards Human Umbilical Vein Endothelial Cells (HUVECs) and Madin-Darby canine kidney (MDCK) cells at high concentrations. Further mechanistic studies demonstrated this multivalent sialyl conjugate showed strong capture and trapping of influenza virions, thus disrupting the ability of the influenza virus to infect host cells. This research lays the experimental foundation for the development of new antiviral agents based on multivalent sialic acid-protein conjugates.


Subject(s)
Influenza, Human , Animals , Dogs , Humans , Antiviral Agents/chemistry , Endothelial Cells/metabolism , Hemagglutinin Glycoproteins, Influenza Virus/metabolism , Hemagglutinins/metabolism , Madin Darby Canine Kidney Cells , N-Acetylneuraminic Acid/metabolism , Neuraminidase/metabolism , Serum Albumin, Human , Viral Proteins/antagonists & inhibitors , Viral Proteins/chemistry , Viral Proteins/metabolism , Virion/metabolism
2.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-940301

ABSTRACT

ObjectiveTo study the chemical constituents of the seeds of Sophora tonkinensis. MethodThe chemical constituents were isolated and purified by chromatography with MCI resin, silica gel, Sephadex LH-20, and semi-preparative high performance liquid chromatography. Their structures were identified by physicochemical properties, spectral data as well as relevant references. Meanwhile, the antibacterial activities against Helicobacter pylori of these compounds were screened by agar dilution method. ResultA total of 22 compounds were isolated from the methanol extract of the seeds of S. tonkinensis, and characterized as 4′,7-dihydroxy-6-methoxy isoflavone (1), daidzein (2), wighteone (3), dalparvone (4), 5,7-dihydroxy-4′-methoxyisoflavone (5), prunetin (6), formononetin (7), genistein (8), 5-methoxydaidzein (9), ononin (10), 7,4′-dihydroxyflavone (11), liquiritigenin (12), bayin (13), 2,4-dihydroxybenzoate (14), methyparaben (15), 4-hydroxyacetophenone (16), p-anisaldehyde (17), methyl indole-3-carboxylate (18), 4-[β-D-apiofuranoyl-(1→6)-O-β-D-glucopyranosyloxy] phenylacetonitrile (19), (-)-methyl dihydrophaseate (20), methyl canavaliol ester (21), vomifoliol 3′-O-β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside (22). ConclusionCompounds 1, 5, 6, 9 and 16 are isolated from S. tonkinensis for the first time, compounds 4, 14, 17-22 are isolated from the genus of Sophora for the first time. In addition, compounds 10 and 13 display moderate antibacterial activities against H. pylori.

SELECTION OF CITATIONS
SEARCH DETAIL
...